計算生物學市場規模、佔有率和成長分析：按生物資訊工具、計算模型、臨床應用、資料管理解決方案、研究服務和地區分類－2026-2033年產業預測

2024 年全球計算生物學市場價值為 6.355 億美元，預計將從 2025 年的 6.9206 億美元成長到 2033 年的 13.6888 億美元，在預測期（2026-2033 年）內以 8.9% 的複合年成長率成長。

全球計算生物學市場正經歷顯著成長，這主要得益於生物學原理與數學和計算技術的日益融合。推動這一成長的關鍵因素包括藥物舉措的激增、對預測建模需求的不斷成長，以及對諸如人類基因組計劃等群體定序項目的大量投資。先進的計算生物學建模技術能夠對複雜的生物系統進行精確的模擬和分析，而計算遺傳學等領域則專注於基因組同源性。在神經學領域，3D模擬模型加深了我們對大腦連接的理解，而計算藥理學則支持對複雜藥物交互作用的建模。隨著新藥研發成本的上升和失敗率的增加，製藥公司正從傳統的臨床試驗轉向預測方法，預計在公共和私人研發資金的支持下，該領域將快速發展。

全球計算生物學市場的成長要素

全球計算生物學市場正蓬勃發展，這主要得益於用於基因測序的先進計算工具的日益普及。這些工具能夠輔助完成諸多任務，包括PCR引子設計、限制性內切酶切割位點確定以及DNA序列到胺基酸序列的轉換。隨著資料庫的不斷擴充和定序軟體的日益普及，研究人員將更容易獲得大量的基因結構及其編碼資訊。計算技術能夠有效率地從大規模資料集中識別功能重要的蛋白質序列，從而促進藥物研發進程。例如，在微生物基因組中發現蛋白質標靶可以帶來疾病治療的突破性進展，並有助於開發商業性價值的酶，因此，電腦預測對於從廣泛的遺傳資源中識別關鍵蛋白質至關重要。

全球計算生物學市場中的限制因素

全球計算生物學市場面臨許多限制因素，主要源自於熟練專業人才短缺和領域內缺乏標準化。計算生物學領域的成功需要精通程式設計、數學和統計學，並對雲端運算和生物科學有深入的理解。然而，該領域的跨學科性質導致缺乏清晰的教育框架，這可能會阻礙應屆畢業生技能的提升。此外，缺乏成熟的調查方法來解決諸如過敏反應和術後併發症等複雜問題，也可能限制市場收入的成長。

全球計算生物學市場趨勢

全球計算生物學市場正經歷強勁成長，這主要得益於人們對藥物基因體學的日益關注以及旨在闡明患者群體遺傳多樣性的臨床研究的增加。這一趨勢加深了我們對生物路徑和基因組因素的理解，從而加快了藥物發現和研究進程。表觀基因、蛋白質組學和總體基因體學的進步，能夠更深入地揭示蛋白質結構和相互作用，進一步推動了市場需求。此外，疾病建模和藥物發現領域的重大技術創新，以及公共和公共部門在研發領域不斷增加的投資，預計將持續促進市場擴張和發展。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球計算生物學市場規模：依生物資訊學工具分類

• 基因組分析
  • 定序工具
  • 變異分析
• 蛋白質體學工具
  • 蛋白質結構分析
  • 質譜軟體

全球計算生物學市場規模：依計算模型分類

• 系統生物學
  • 網路建模
  • 路徑分析
• 預測建模
  • 機器學習模型
  • 統計模型

全球計算生物學市場規模：依臨床應用分類

• 藥物發現
  • 目標識別
  • 臨床試驗分析
• 個人化醫療
  • 基因譜分析
  • 治療結果

全球計算生物學市場規模：按資料管理解決方案分類

• 資料閘道器
  • 雲端儲存系統
  • 資料庫管理系統
• 資料整合
  • 互通性解決方案
  • 資料工作流程自動化

全球計算生物學市場規模：依研究服務分類

• 諮詢服務
  • 技術諮詢
  • 監理合規
• 委託研究
  • 實驗室服務
  • 分析服務

全球計算生物學市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Illumina
• Thermo Fisher Scientific
• 10x Genomics
• Sage BioNetworks
• BERG Health
• Bioinformatics Solutions
• Genomatica
• GRAIL
• Strateos
• Benchling
• BioSymetrics
• Evotec
• Convergent Genomics
• Adaptive Biotechnologies
• Insilico Medicine
• Synlogic
• Genomatix
• Alethia Biotherapeutics
• Recursion Pharmaceuticals
• Accellix

結論與建議

Global Computational Biology Market size was valued at USD 635.5 Million in 2024 and is poised to grow from USD 692.06 Million in 2025 to USD 1368.88 Million by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

The market for global computational biology is experiencing notable growth driven by the increasing integration of biological principles with mathematical and computational techniques. Key factors contributing to this expansion include the surge in drug discovery initiatives, the rising need for predictive modeling, and significant investments in population-based sequencing projects like the Human Genome Project. Advanced computational bio-modeling techniques enable precise simulation and analysis of complex biological systems, while fields like computational genetics focus on genomic homology. In neurology, 3D simulation models enhance the understanding of brain connectivity, and computational pharmacology aids in modeling intricate drug interactions. As pharmaceutical companies shift from traditional clinical trials to predictive methodologies, driven by escalating costs and drug failure rates, this sector is poised for rapid advancement, spurred by public and private R&D funding.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Computational Biology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Computational Biology Market Segments Analysis

Global Computational Biology Market is segmented by Bioinformatics Tools, Computational Models, Clinical Applications, Data Management Solutions, Research Services and region. Based on Bioinformatics Tools, the market is segmented into Genomic Analysis and Proteomics Tools. Based on Computational Models, the market is segmented into Systems Biology and Predictive Modeling. Based on Clinical Applications, the market is segmented into Drug Discovery and Personalized Medicine. Based on Data Management Solutions, the market is segmented into Data Storage and Data Integration. Based on Research Services, the market is segmented into Consulting Services and Outsourced Research. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Computational Biology Market

The Global Computational Biology market is experiencing growth driven by the increasing availability of advanced computational tools for genome sequencing. These tools aid in numerous tasks, such as creating PCR primers, identifying restriction enzyme cut sites, and converting DNA sequences into amino acid sequences. As databases expand and sequence analysis software becomes more accessible, researchers can effortlessly access vast information regarding gene structures and their encoded messages. Computational techniques enhance drug development by efficiently identifying functionally significant protein sequences within large datasets. For example, discovering protein targets in microbial genomes can lead to breakthroughs in disease treatment and the development of commercially valuable enzymes, making computer-based predictions crucial for identifying key proteins from extensive genetic resources.

Restraints in the Global Computational Biology Market

The global computational biology market faces significant constraints primarily due to a shortage of skilled professionals and a lack of standardization in the field. Proficiency in programming, mathematics, statistics, and a robust understanding of both cloud computing and biological sciences are essential for success in computational biology. However, the interdisciplinary nature of the field contributes to the absence of a defined educational framework, which can impede the development of skills among emerging graduates. Furthermore, the absence of established methodologies for addressing complex challenges, such as allergic reactions and postoperative complications, is likely to restrict revenue growth in the market.

Market Trends of the Global Computational Biology Market

The global computational biology market is experiencing robust growth driven by an increasing focus on pharmacogenomics and the rise in clinical studies aimed at understanding the genetic diversity among patient populations. This trend enhances knowledge of biological pathways and genomic factors, thereby accelerating drug discovery and research timelines. Demand is further fueled by advancements in epigenomics, proteomics, and metagenomics, facilitating deeper insights into protein structures and interactions. Additionally, significant technological innovations in disease modeling and drug development, coupled with rising investments from both private and public sectors in research and development, are poised to sustain market expansion and evolution.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Computational Biology Market Size by Bioinformatics Tools & CAGR (2026-2033)

• Market Overview
• Genomic Analysis
  • Sequencing Tools
  • Variant Analysis
• Proteomics Tools
  • Protein Structure Analysis
  • Mass Spectrometry Software

Global Computational Biology Market Size by Computational Models & CAGR (2026-2033)

• Market Overview
• Systems Biology
  • Network Modeling
  • Pathway Analysis
• Predictive Modeling
  • Machine Learning Models
  • Statistical Models

Global Computational Biology Market Size by Clinical Applications & CAGR (2026-2033)

• Market Overview
• Drug Discovery
  • Target Identification
  • Clinical Trials Analytics
• Personalized Medicine
  • Genetic Profiling
  • Therapeutic Outcomes

Global Computational Biology Market Size by Data Management Solutions & CAGR (2026-2033)

• Market Overview
• Data Storage
  • Cloud Storage Systems
  • Database Management Systems
• Data Integration
  • Interoperability Solutions
  • Data Workflow Automation

Global Computational Biology Market Size by Research Services & CAGR (2026-2033)

• Market Overview
• Consulting Services
  • Technical Consulting
  • Regulatory Compliance
• Outsourced Research
  • Laboratory Services
  • Analytical Services

Global Computational Biology Market Size & CAGR (2026-2033)

• North America (Bioinformatics Tools, Computational Models, Clinical Applications, Data Management Solutions, Research Services)
  • US
  • Canada
• Europe (Bioinformatics Tools, Computational Models, Clinical Applications, Data Management Solutions, Research Services)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Bioinformatics Tools, Computational Models, Clinical Applications, Data Management Solutions, Research Services)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Bioinformatics Tools, Computational Models, Clinical Applications, Data Management Solutions, Research Services)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Bioinformatics Tools, Computational Models, Clinical Applications, Data Management Solutions, Research Services)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sage BioNetworks
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BERG Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioinformatics Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GRAIL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Strateos
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Benchling
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioSymetrics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Convergent Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adaptive Biotechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insilico Medicine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synlogic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alethia Biotherapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recursion Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accellix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations